期刊文献+

2型糖尿病患者游离脂肪酸水平与颈动脉内膜中层厚度的关系 被引量:2

Correlation of free fatty acids with carotid artery intima-media thickness in patients with type 2 diabetes
原文传递
导出
摘要 对70例2型糖尿病患者、22例糖耐量异常者与35例糖耐量正常者,行空腹血游离脂肪酸(fFFA)、口服糖耐量试验2h游离脂肪酸(2hFFA)及稳态模型胰岛素抵抗指数(HOMA-IR)、游离脂肪酸曲线下面积(AUC_FFA)和颈动脉内膜中层厚度(IMT)测定。2型糖尿病患者的平均HOMA-IR、fFFA、2hFFA、AUC_FFA、IMT水平分别为3.3±3.2、(0.55±0.20)mmol/L、(0.28±0.18)mmol/L、(0.83±0.34)mmol·L-1·h-1 和(0.12±0.05)cm,高于糖耐量正常者的1.9±1.3、(0.41±0.15)mmol/L、(0.12±0.10)mmol/L、(0.53±0.20)mmol·L-1·h-1和(0.09±0.03)cm。HOMA-IR、IMT与fFFA、2hFFA、AUC_FFA均呈正相关(均P〈0.05)。提示空腹及糖负荷后游离脂肪酸水平与胰岛素抵抗及糖尿病患者颈动脉IMT有一定相关性。 Seventy patients with type 2 diabetes (T2DM), 23 subjects with impaired glucose tolerance (IGT) and 35 individuals with normal glucose tolerance (NGT) were recruited in the study. Fasting free fatty acids (fFFA) and postprandial free fatty acids (2 hFFA) after oral glucose tolerance test (OGTT) were measured; homeostasis model assessment of insulin resistance (HOMA-IR), area under the curve of free fatty acids (AUC_FFA ) were calculated. The carotid artery intima-media thickness (IMT) was assessed by color ultrasonography. HOMA-IR, fFFA, 2 hFFA, AUC_FFA and IMT in T2DM group were 3.3 ± 3.2, ( 0. 55 ± 0. 20 ) mmol/L , ( 0. 28 ±0. 18)mmol/L, (0.83±0.34)mmol . L-1 . h-1 and (0.12± 0.05 ) cm, which were significantly higher than those in NGT group, respectively [ 1.9 ± 1.3, ( 0.41±0. 15)mmol/L,(0. 12 ±0. 10) mmol/L, (0. 53 ±0. 20)mmol .L-1 . h-1 and (0. 09 ±0. 03)cm, all P 〈 0. 05 ]. Both HOMA-IR and IMT were positively correlated with fFFA, 2 hFFA and AUC_FFA ( all P 〈 0. 05 ). The results indicate that the levels of fasting and postprantial free fatty acid were related with insulin resistance and atherosclerosis of carotid artery.
出处 《中华全科医师杂志》 2013年第5期394-396,共3页 Chinese Journal of General Practitioners
关键词 颈动脉内膜中层厚度 胰岛素抵抗 游离脂肪酸 Carotid artery intima-media thickness Insulin resistance Free fatty acids
  • 相关文献

参考文献11

  • 1Bokemark L, Wikstrand J, Attvall S, et al. Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Internal Med,2001,249 :59-67.
  • 2Stemberg I-IO,Paridisi G,Hook G, et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitricoxide production. Diabetes, 2000,49 : 1231-1238.
  • 3Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes melhtus provisional report of a WHO consultation, Diabet Med, 1998,15:539-553.
  • 4霍娟,傅汉菁.血清游离脂肪酸与胰岛β细胞功能及胰岛素抵抗[J].华西医学,2010,25(7):1255-1258. 被引量:10
  • 5Bajaj M,Berria R,Pratipanawatr T, et al. Free fatty acid induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans. Am J Physiol Endocrinol Metab,2002, 283:346-352.
  • 6Sunayama S, Watanabe Y, Daida H, et al. Thiazolidinediones, dyslipidaemia and insulin resistance syndrome. Curr Opin Lipidol, 2000,11:397-402.
  • 7Carlsson M, Wessman Y, Almgren P, et al. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Throm Vasc Biol, 2000,20: 1588-1594.
  • 8岳峰,武顺,张铁,陈少华,李曙远.2型糖尿病单纯脂肪餐后TG、FFA与颈动脉内中膜厚度的关系[J].中国医学工程,2010,18(4):93-94. 被引量:2
  • 9Schwartz EA, Reaven PD. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am ,2006,35:525-549.
  • 10Sutton BS,Palmer ND,Langefeld CD,et al. Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study. Diabetes, 2009, 58 : 1457-1462.

二级参考文献24

  • 1Seltzer HS, Allen EW, Herron AL Jr,et al. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus[J]. J Clin Invest,1967,46(3):323-335.
  • 2Lupi R, Dotta F, Marselli L, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated [J]. Diabetes, 2002,51 (5) : 1437-1442.
  • 3Lameloise N, Muzzin P, Prentki M, et al. Uncoupling protein 2 : a possible link between fatty acid exeess and impaired glueose-indueed insulin secretion? [J].Diabetes,2001,50(4):803-809.
  • 4Gremlich S, Bonny C, Waeber G, et al. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels[J]. J Biol Chem, 1997, 272(48) : 30261-30269.
  • 5Riedel MJ, Boora P, Steckley D, et al. Kir6. 2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes? [J] Diabetes, 2003, 52 (10): 2630-2635.
  • 6Poitout V, Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity [J]. Endocrinology, 2002,143(2) : 339-342.
  • 7Cnop M, Hannaert JC, Hoorens A,et al. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet ceils and cellular triglyeeride accumulation [J ]. Diabetes, 2001, 50 (8) : 1771-1777.
  • 8Chen YD, Golay A, Swislocki AL, et al. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab, 1987,64(1) : 17-21.
  • 9World Health Organization Definition,Diagnosis and Classification of Diabetes Mellitusand its Complications. Report of a WHO Consuhation. Geneva, World Health Org. , Dept. of Noncommunicable Disease Surveillance, 1999.
  • 10Nina Mohanlal, Rury R Holman. A standardized triglyceride and carbohydrate challenge. Diabetes care[J]. 2004,27( 1 ) :93 -94.

共引文献19

同被引文献22

  • 1Giovanni Targher,Alessandro Mantovani, Isabella Pichiri. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes[J]. Clinical Science ,2013, 125(6) :301-309.
  • 2Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease [J]. The Annals of Pharmacotherapy, 2010,44 ( 10 ) : 1655- 1659.
  • 3Stefano Bonapace, Gianluea Perseghin, Giulio Molon. Non- alcoholic fatty liver disease is associated with left ventric- ular diastolic dysfunction in patients with type 2 diabetes[J]. Diabetes Care,2012,35 (2) :389-395.
  • 4Sunder Mudaliar,Robert RH,Arun JS,et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liv- er disease[J]. Gastroenterology, 2013,145 (3) : 574-582.
  • 5Nolan CJ. Failure of islet beta-cell compensation for in- sulin resistance causes type 2 diabetes: What causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Journal of Gastroenterology and Hep- atology,2010,25 (10) : 1594-1597.
  • 6Konstantinos Tziomalos,Vassilios GA,Asterios Karagian- nis. Non-alcoholic fatty liver disease in type 2 diabetes : Pathogenesis and treatment options[J]. Current Vascu- lar Pharmacology,2012,10(2) : 162-172.
  • 7Marcin Kosmalski,Jacek Kasznicki ,Jozef Drzewoski. Re- lationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes[J]. Polskie Archiwum Medycyny Wewntrznej ,2013,123(9) :436--442.
  • 82007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:269
  • 9胡大一,徐希平.有效控制“H型”高血压——预防卒中的新思路[J].中华内科杂志,2008,47(12):976-977. 被引量:741
  • 10非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1161

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部